JP2023116498A5 - - Google Patents

Download PDF

Info

Publication number
JP2023116498A5
JP2023116498A5 JP2023084640A JP2023084640A JP2023116498A5 JP 2023116498 A5 JP2023116498 A5 JP 2023116498A5 JP 2023084640 A JP2023084640 A JP 2023084640A JP 2023084640 A JP2023084640 A JP 2023084640A JP 2023116498 A5 JP2023116498 A5 JP 2023116498A5
Authority
JP
Japan
Prior art keywords
aqueous pharmaceutical
pharmaceutical formulation
dexamethasone
less
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023084640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023116498A (ja
Filing date
Publication date
Priority claimed from JP2020529561A external-priority patent/JP7337060B2/ja
Application filed filed Critical
Publication of JP2023116498A publication Critical patent/JP2023116498A/ja
Publication of JP2023116498A5 publication Critical patent/JP2023116498A5/ja
Pending legal-status Critical Current

Links

JP2023084640A 2018-11-14 2023-05-23 安定なグルココルチコイド製剤 Pending JP2023116498A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862767448P 2018-11-14 2018-11-14
US62/767,448 2018-11-14
JP2020529561A JP7337060B2 (ja) 2018-11-14 2019-11-14 安定なグルココルチコイド製剤
PCT/US2019/061363 WO2020102474A1 (en) 2018-11-14 2019-11-14 Stable glucocorticoid formulation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020529561A Division JP7337060B2 (ja) 2018-11-14 2019-11-14 安定なグルココルチコイド製剤

Publications (2)

Publication Number Publication Date
JP2023116498A JP2023116498A (ja) 2023-08-22
JP2023116498A5 true JP2023116498A5 (cg-RX-API-DMAC7.html) 2023-11-17

Family

ID=68808595

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020529561A Active JP7337060B2 (ja) 2018-11-14 2019-11-14 安定なグルココルチコイド製剤
JP2023084640A Pending JP2023116498A (ja) 2018-11-14 2023-05-23 安定なグルココルチコイド製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020529561A Active JP7337060B2 (ja) 2018-11-14 2019-11-14 安定なグルココルチコイド製剤

Country Status (13)

Country Link
US (1) US12653891B2 (cg-RX-API-DMAC7.html)
EP (1) EP3706721A1 (cg-RX-API-DMAC7.html)
JP (2) JP7337060B2 (cg-RX-API-DMAC7.html)
KR (2) KR102444113B1 (cg-RX-API-DMAC7.html)
CN (1) CN111918645A (cg-RX-API-DMAC7.html)
AU (1) AU2019378874B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021009365A2 (cg-RX-API-DMAC7.html)
CA (1) CA3118505A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191345A1 (cg-RX-API-DMAC7.html)
IL (1) IL283199A (cg-RX-API-DMAC7.html)
MX (1) MX2021005665A (cg-RX-API-DMAC7.html)
SG (1) SG11202104702VA (cg-RX-API-DMAC7.html)
WO (1) WO2020102474A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247000A1 (en) 2020-06-01 2021-12-09 Avm Biotechnology, Llc Methods of treatment using icam-modulating agents
US12706617B2 (en) 2023-04-27 2026-08-11 Hewlett Packard Enterprise Development Lp Selective filtering to reduce interferences in Wi-Fi communications
US12609718B2 (en) 2023-06-14 2026-04-21 Hewlett Packard Enterprise Development Lp WiFi-7 optimized split band architecture and method of operation
CN116789728B (zh) * 2023-06-16 2026-02-06 山东斯瑞药业有限公司 一种降低糖皮质激素原料药重金属元素杂质含量的工艺
CN116807970A (zh) * 2023-07-26 2023-09-29 遂成药业股份有限公司 一种地塞米松磷酸钠注射液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136607A (en) * 1995-11-02 2000-10-24 Bayer Corporation Multi-analyte reference solutions with stable pO2 in zero headspace containers
US20040197333A1 (en) * 2000-02-10 2004-10-07 Cornell Research Foundation, Inc. Use of TGF-beta antagonists to inhibit tumor cell formation or progression
US9694103B2 (en) * 2003-04-16 2017-07-04 The Children's Hospital Of Philadelphia Photochemical activation of surfaces for attaching biomaterial
US20050244472A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
JP4598484B2 (ja) * 2004-11-11 2010-12-15 テルモ株式会社 塩酸リトドリン注射液製剤
CN101340916A (zh) * 2005-12-22 2009-01-07 兴和株式会社 类固醇的经时稳定性得到改善的外用制剂
AU2013200089B2 (en) * 2006-02-09 2016-03-03 Santen Pharmaceutical Co., Ltd Stable formulations, and methods of their preparation and use
EP2249801A2 (en) 2008-02-07 2010-11-17 Amgen Inc. Stabilized protein compositions
CN101623291B (zh) 2008-07-07 2011-12-07 天津金耀集团有限公司 一种地塞米松磷酸钠注射液
US20110281834A1 (en) * 2008-11-10 2011-11-17 Friden Phillip M Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid
JP2011136973A (ja) * 2009-12-28 2011-07-14 Keiki Imoto 安定なエダラボン含有水性製剤
GB2477545B (en) * 2010-02-05 2011-12-21 Special Products Ltd A liquid morphine composition for buccal administration
BR112013003169B1 (pt) 2010-08-18 2022-05-24 Theresa Deisher Uso de um agente terapêutico que inibe a ligação de células-tronco a tecido linfóide
US10426740B1 (en) 2010-08-18 2019-10-01 Avm Biotechnology, Llc Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
AU2012204501B2 (en) 2011-01-03 2016-05-19 Avm Biotechnology, Llc Personalized production of biologics and method for reprogramming somatic cells
ITMI20122002A1 (it) 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
JP6741286B2 (ja) * 2013-03-28 2020-08-19 テルモ株式会社 包装されたアセトアミノフェン注射液製剤の製造方法
KR101485243B1 (ko) * 2013-05-08 2015-01-21 씨제이헬스케어 주식회사 안정화된 페메트렉시드 제제
GR1008921B (el) 2015-12-10 2017-01-12 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη
CN110475571B (zh) * 2017-04-01 2023-04-04 Avm生物技术有限责任公司 细胞免疫疗法前细胞毒性预调理的替代
CN107375200A (zh) 2017-06-16 2017-11-24 北京立时达药业有限公司 一种地塞米松磷酸钠注射液及其制备方法
EP3488851A1 (en) 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies

Similar Documents

Publication Publication Date Title
CN102985071B (zh) 透析前体组合物
US3970750A (en) Effervescent potassium chloride composition
CN103796634B (zh) 透析前体组合物
US20150283240A1 (en) Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
CN103747789B (zh) 透析前体组合物
JP2025163108A5 (cg-RX-API-DMAC7.html)
JP2009521521A5 (cg-RX-API-DMAC7.html)
CN102946886A (zh) 透析前体组合物
JP2008542237A5 (cg-RX-API-DMAC7.html)
JP2015506981A5 (cg-RX-API-DMAC7.html)
JP2009521473A5 (cg-RX-API-DMAC7.html)
HU230738B1 (hu) Ketotifén tartalmú szemészeti készítmény
JP2006512286A5 (cg-RX-API-DMAC7.html)
JP2021513521A5 (cg-RX-API-DMAC7.html)
CN1953754A (zh) 腹膜透析溶液
PT90356B (pt) Processo para a preparacao de composicoes farmaceuticas contendo solucoes aquosas de pentamidina
CN104010645A (zh) 透析前体组合物
RU96109524A (ru) Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для иньекций
JP4956981B2 (ja) オキシメタゾリン含有水性組成物
CN115137699B (zh) 一种增效防腐的右美托咪定鼻喷剂
JP4806956B2 (ja) 点眼用液剤
US8853265B2 (en) Oral composition to reduce cold symptoms and duration of same
TW200505469A (en) Glycyrrhizin containing pharmaceutical composition
JP5111372B2 (ja) 安定および保存化ケトチフェン眼用組成物
JPH10139666A (ja) 液剤およびその製造方法